Post Job

Explore Jobs

Find Specific Jobs

Explore Careers

Explore Professions

Best Companies

Explore Companies

I

Working at ImmunoGen

Zippia Score 4.8

Overview

JobsSalaryRevenueReviewsDemographicsCompetitorsCEO & Executives

ImmunoGen overview

Industry
Biopharmaceuticals
Revenue
$108.8M
Headquarters
Waltham, MA
Employees
75
Founded In
Website
Organization Type
Public
CEO
Mark Joseph Enyedy
Social Media
ImmunoGen, Inc. engages in the research and development of antibody-based anticancer therapeutics in the United States. The company develops therapeutics for the treatment of cancer using its Targeted Antibody Payload (TAP) technology, which uses antibodies to deliver a potent cytotoxic agent. Its products include Trastuzumab-DM1, a Phase II clinical trial product for the treatment of metastatic breast cancer; IMGN901, a Phase I clinical trial product to treat hematological malignancies, including multiple myeloma, small-cell lung cancer, Merkel cell carcinoma, and other cancers of neuroendocrine origin; SAR3419, a Phase I clinical trial product for the treatment of B-cell hematological malignancies, including non-Hodgkin's lymphoma; and IMGN388 and BIIB015, which are in Phase I clinical trials for the treatment of solid tumors. The company's products also comprise BT-062, a Phase I clinical trial product targeting multiple myeloma; SAR566658, a preclinical trail product for the treatment of breast, ovarian, and other solid tumors; SAR650984, a preclinical trail product to treat hematological malignancies; and TAP and other compounds. It has licensing or collaboration agreements with sanofi-aventis; Genentech, Inc.; Biotest AG; Bayer HealthCare AG; Biogen Idec; Amgen, Inc.; Centocor, Inc.; Cytovance Biologics LLC; Laureate Pharma, Inc.; BioInvent International AB; Diosynth RTP, Inc.; and Societa Italiana Corticosteroidi S.r.l. ImmunoGen was founded in 1981 and is headquartered in Waltham, Massachusetts.
The staff at ImmunoGen come from unusually diverse demographic backgrounds. The company is 41.9% female and 37.9% ethnic minorities. Despite its diversity in other areas, ImmunoGen employees are noticeably lacking in political diversity. It has an unusually high proportion of employees who are members of the Democratic Party, at 76.0%. Employees seem to enjoy working in an otherwise diverse workplace that is dominated by members of the Democratic Party. ImmunoGen has great employee retention with staff members usually staying with the company for 4.5 years.The average employee at ImmunoGen makes $64,247 per year. Pay at ImmunoGen is significantly lower than some of its highest paying competitors, like Exelixis, Eli Lilly and Company, and Acorda Therapeutics, which pay $108,978, $100,905, and $97,279, respectively.
Based in Waltham, MA, ImmunoGen is a small pharmaceutical company with only 75 employees and an annual revenue of $108.0M.

ImmunoGen's Mission Statement

Targeting a better life for people with cancer is why we get up in the morning. It's not enough to disrupt the progress of someone's cancer; we want to keep cancer from disrupting someone's life. That's why everything we do is about developing the most precise, targeted cancer therapies.

Zippi Waving Small

In demand companies are hiring!

Let us apply for you!

-

ImmunoGen employee reviews

Be the first to review!

Do you work at ImmunoGen?

Help job seekers learn about working at ImmunoGen

Average salary at ImmunoGen
$64,247 yearly
See all salaries

On This Page

Be The First To Review ImmunoGen

Anonymously rate your employee experience

Your Opinion can Help Other Job Seekers

Do You Like Working At ImmunoGen?

The team at ImmunoGen

  • The key people at ImmunoGen is Mark Joseph Enyedy.
Key People
M
Mark Joseph Enyedy

ImmunoGen Rankings

ImmunoGen is ranked #38 on the Best Pharmaceutical Companies to Work For in America list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

ImmunoGen salaries

9.5
Salary Score
The average an ImmunoGen salary in the United States is $64,247 per year. ImmunoGen employees in the top 10 percent can make over $120,000 per year, while ImmunoGen employees at the bottom 10 percent earn less than $34,000 per year.
Average ImmunoGen Salary
$64,247
yearly
$30.89 hourly
Updated March 14, 2024

And if you're looking for a job, here are the top jobs ImmunoGen is hiring right now:

  1. Director
  2. Senior Scientist
  3. Group Leader
  4. SQL Server Developer
  5. Medical Science Liaison

Evaluate ImmunoGen's commitment to diversity and inclusion.

Zippia waving zebra

ImmunoGen diversity

9.8
Diversity Score
We calculated ImmunoGen’s diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of ImmunoGen’s workforce.
ImmunoGen diversity summary. Zippia estimates ImmunoGen's demographics and statistics using a database of 30 million profiles. Zippia verifies estimates with BLS, Census, and current job openings data for accuracy. We calculated ImmunoGen's diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of ImmunoGen's workforce.
  • ImmunoGen has 75 employees.
  • 42% of ImmunoGen employees are women, while 58% are men.
  • The most common ethnicity at ImmunoGen is White (62%).
  • 16% of ImmunoGen employees are Asian.
  • 13% of ImmunoGen employees are Hispanic or Latino.
  • The average employee at ImmunoGen makes $64,247 per year.
  • ImmunoGen employees are most likely to be members of the democratic party.
  • Employees at ImmunoGen stay with the company for 4.5 years on average.
I

Do you work at ImmunoGen?

Does ImmunoGen actively promote diversity and inclusion?

ImmunoGen Financial Performance

9.8
Performance Score

We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

ImmunoGen currently has 108.8M in revenue. ImmunoGen's most recent quarter produced 113.4m (q3'2023).

ImmunoGen annual revenue

$132M
$106M
$79M
$53M
$26M
$0
2017
2018
2019
2020
2021
2022

Highest paying ImmunoGen competitors

Compare ImmunoGen salaries to competitors, including Exelixis, Eli Lilly and Company, and Acorda Therapeutics. Employees at Exelixis earn the highest average yearly salary of $108,978. The salaries at Eli Lilly and Company average $100,905 per year, and the salaries at Acorda Therapeutics come in at $97,279 per year.

Are You An Executive, HR Leader, Or Brand Manager At ImmunoGen?

Claiming and updating your company profile on Zippia is free and easy.

ImmunoGen FAQs

Have more questions? See all answers to common company questions.

Search for jobs

Most Common Locations At ImmunoGen

Related Companies

Related Company Jobs

Cities With ImmunoGen Jobs

Related Companies

Updated March 14, 2024

Zippia gives an in-depth look into the details of ImmunoGen, including salaries, political affiliations, employee data, and more, in order to inform job seekers about ImmunoGen. The employee data is based on information from people who have self-reported their past or current employments at ImmunoGen. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by ImmunoGen. The data presented on this page does not represent the view of ImmunoGen and its employees or that of Zippia.

ImmunoGen may also be known as or be related to IMMUNOGEN INC., ImmunoGen, ImmunoGen Inc, ImmunoGen Inc., ImmunoGen, Inc., Immunogen Inc. and Immunogen, Inc.